ResearcherNantong UniversityActive in the last 2 years
Qingsong Guo
Matched on ORCID iD 0000-0001-5194-2370; OpenAlex author ID A5054812652. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 7
- Stiffness-Activated Stellate Cells Drive Pancreatic Cancer Liver Colonization via GMFG-TNS4 Signaling. Co-author DOI 10.1002/advs.76173↗
- PLAAT2 facilitates the development of pancreatic cancer and serves as a predictor of resistance to chemotherapy. Last author DOI 10.1186/s12885-025-15481-2↗
- Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associated macrophages recruitment and M2-like p… Co-author DOI 10.1016/j.ijbiomac.2024.131826↗
- Long non-coding RNA LINC00930 targeting miR-6792-3p/ZBTB16 regulates the proliferation and EMT of pancreatic cancer. Co-author DOI 10.1186/s12885-024-12365-9↗
- Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker. First author DOI 10.1007/s00432-023-05161-8↗
- MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. Co-author DOI 10.1186/1471-2407-14-85↗
- Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2013.07.009↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuhua Lu · 6 shared papers, 2013–2026 · strength 1.02
- Paper Stiffness-Activated Stellate Cells Drive Pancreatic Cancer Liver Colonization via GMFG-TNS4 Signaling. DOI 10.1002/advs.76173↗
- Paper PLAAT2 facilitates the development of pancreatic cancer and serves as a predictor of resistance to chemotherapy. DOI 10.1186/s12885-025-15481-2↗
- Paper Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associat… DOI 10.1016/j.ijbiomac.2024.131826↗
- Xiaohong Li · 4 shared papers, 2013–2025 · strength 0.55
- Paper PLAAT2 facilitates the development of pancreatic cancer and serves as a predictor of resistance to chemotherapy. DOI 10.1186/s12885-025-15481-2↗
- Paper Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associat… DOI 10.1016/j.ijbiomac.2024.131826↗
- Paper MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. DOI 10.1186/1471-2407-14-85↗
- Qiyang Chen · 2 shared papers, 2023–2025 · strength 0.47
- Yibing Guo · 2 shared papers, 2024 · strength 0.43
- Paper Long non-coding RNA LINC00930 targeting miR-6792-3p/ZBTB16 regulates the proliferation and EMT of pancreatic cancer. DOI 10.1186/s12885-024-12365-9↗
- Paper Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associat… DOI 10.1016/j.ijbiomac.2024.131826↗
- Xihao Yao · 2 shared papers, 2024 · strength 0.43
- Paper Long non-coding RNA LINC00930 targeting miR-6792-3p/ZBTB16 regulates the proliferation and EMT of pancreatic cancer. DOI 10.1186/s12885-024-12365-9↗
- Paper Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associat… DOI 10.1016/j.ijbiomac.2024.131826↗
- Zhiwei Wang · 3 shared papers, 2013–2023 · strength 0.27
- Paper Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker. DOI 10.1007/s00432-023-05161-8↗
- Paper MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell. DOI 10.1186/1471-2407-14-85↗
- Paper Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. DOI 10.1016/j.canlet.2013.07.009↗
- Biwen Zhu · 1 shared paper, 2026 · strength 0.27
- Jiashuai Yan · 1 shared paper, 2026 · strength 0.27
- Xiaoqi Guan · 1 shared paper, 2026 · strength 0.27
- Yibing Guo · 1 shared paper, 2026 · strength 0.27
- Yuhua Lu · 1 shared paper, 2024 · strength 0.22
- Yingqing Mao · 1 shared paper, 2024 · strength 0.22
- Yao Wang · 1 shared paper, 2024 · strength 0.22
- Di Wu · 1 shared paper, 2024 · strength 0.21
- Tiancheng Gong · 1 shared paper, 2024 · strength 0.21
- Lei Wang · 2 shared papers, 2013–2014 · strength 0.07
- Mingyan Zhu · 2 shared papers, 2013–2014 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.